Rating

Avid Service Awards Honors Top Homebuilder Employees in the U.S.

Retrieved on: 
Thursday, April 28, 2022
Architecture, Commercial Building & Real Estate, Construction & Property, Building Systems, Urban Planning, Other Construction & Property, Interior Design, Residential Building & Real Estate, Industry, Communication, Rating, Gunsmith

Avid Ratings proudly announces the 9th Annual Avid Service Awards, recognizing the top homebuilding professionals in the United States and Canada.

Key Points: 
  • Avid Ratings proudly announces the 9th Annual Avid Service Awards, recognizing the top homebuilding professionals in the United States and Canada.
  • The Avid Service Awards were created to honor employees who received exemplary customer satisfaction scores amongst the thousands of employees rated in the AvidCX survey program.
  • The Avid Service Award is widely considered to be a premier award for homebuilding professionals.
  • Avid Ratings is proud to present the Avid Service Awards to this years winners.

Shopper Army's New Collaboration with Walmart Canada will help Brands Generate Trusted Incentivized Ratings & Reviews on Walmart.ca

Retrieved on: 
Thursday, April 28, 2022
People, Walmart, Marketing, CBA, Real, Canada, Presidential Council on Nation Branding, Korea, Competition Bureau, Research, Competition, Efficiency, Decision-making, Johnson & Johnson, Brand, Element, Affordable Care Act Health Insurance Rate Review Program, Observation, Honeywell, McCarthy Tétrault, P&G, Review, KPI-driven code analysis, Walmart Canada, Trust, Online shopping, Rating, Unilever

TORONTO, April 28, 2022 /CNW/ - Today, Shopper Army announces their official collaboration with Walmart Canada.

Key Points: 
  • TORONTO, April 28, 2022 /CNW/ - Today, Shopper Army announces their official collaboration with Walmart Canada.
  • Walmart Canada is committed to bringing Canadians the best possible shopping experience and Ratings & Reviews are a big part of this strategy.
  • Shopper Army and BrandSpark have conducted extensive research on the elements that contribute towards trusted reviews along with the role of incentivized Ratings & Reviews on e-commerce platforms.
  • To access Shopper Army's Incentivized Ratings & Reviews Best Practices OR to get your Walmart Ratings & Reviews campaign started, please contact:

The Digital Go-to-Market: Shoppers Now Buying Groceries Online at More Than Four Times the Rate of Purchase in 2017

Retrieved on: 
Tuesday, April 5, 2022
Adoption, Catalog, PowerReviews, CPG, Gen, Ageing, UGC, Rating, Habit, Â, Technology, GLOBE, Generation Z, Solution, Amazon Fresh, Online shopping, Grocery store, Retail, Boomer, Millennials

CHICAGO, April 05, 2022 (GLOBE NEWSWIRE) -- Two years into the pandemic, US grocery consumers continue to shift their buying habits online and the way grocers market their products is shifting too. The grocery sector, once a laggard in digital experience, is surging ahead to keep pace with consumer expectations, including the need to showcase social proof via product reviews – on grocery websites and mobile apps.

Key Points: 
  • These insights are from a new survey from PowerReviews, a leading provider of ratings and reviews technology solutions.
  • The PowerReviews Meeting Grocery and CPG Shopper Digital Expectations in the Post Pandemic Era study draws on survey responses from 11,162 grocery shoppers across the country, surveyed in February 2022.
  • The largest portion (28%) of consumers shop for groceries online monthly, and 25% do so once per week.
  • 90% of online grocery shoppers read ratings and reviews at least occasionally up significantly from 82% in 2021.

Humanigen Reports Year-End 2021 Financial Results

Retrieved on: 
Monday, February 28, 2022
Science, Stem Cells, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, SHIELD, Chronic myelomonocytic leukemia, Cytokine release syndrome, Infection, CMML, The Lancet, DLBCL, National Institute of Allergy and Infectious Diseases, Research, COVID-19, Oxygen toxicity, National, Clinical trial, Rating, Sale, Safety, Degenerative disease, Neurotoxicity, Steroid, Emergency Use Authorization, ORR, EUA, FDA, R, Nasdaq, Patient, Union, CRS, Survival, C-reactive protein, Standard of care, B-cell lymphoma, National Institute, Research and development, Pharmaceutical industry, Lenzilumab, Lancet

Humanigen, Inc. (Nasdaq: HGEN) (Humanigen), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm with its lead drug candidate, lenzilumab, today reported financial results for the year ended December 31, 2021, and announced corporate objectives for 2022.

Key Points: 
  • Humanigen, Inc. (Nasdaq: HGEN) (Humanigen), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm with its lead drug candidate, lenzilumab, today reported financial results for the year ended December 31, 2021, and announced corporate objectives for 2022.
  • Net cash used in operating activities, net of balance sheet changes, was $184.0 million for the year ended December 31, 2021.
  • Subsequent to December 31, 2021, the company raised net proceeds of approximately $3.7 million under its At-the-Market offering program.
  • A summary of key financial highlights as of and for the years ended December 31, 2021 and 2020 is as follows ($ in thousands):
    Three Months Ended December 31,

Verisk Maplecroft Launches Sovereign ESG Ratings

Retrieved on: 
Thursday, February 17, 2022
Rating, Social Security Government Pension Offset, Government, Climate, Cluster analysis, Social, Movement, Research, Biophysical environment, ESG, GLOBE, Security (finance), Lithium, Verisk Analytics, Sovereign

LONDON, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Verisk Maplecroft, a global risk analytics business of Verisk (Nasdaq: VRSK ), has launched new Sovereign ESG Ratings to provide investors with the most comprehensive picture available of ESG risks and opportunities across the entire current and potential sovereign issuer universe.

Key Points: 
  • LONDON, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Verisk Maplecroft, a global risk analytics business of Verisk (Nasdaq: VRSK ), has launched new Sovereign ESG Ratings to provide investors with the most comprehensive picture available of ESG risks and opportunities across the entire current and potential sovereign issuer universe.
  • The Sovereign ESG Ratings, which feature six years of quarterly historical data, draw on approximately 350 of Verisk Maplecrofts 1200+ indicators across 37 separate issues and nine ESG dimensions.
  • With access to Verisk Maplecrofts Sovereign ESG Ratings, investors of all types will be better positioned to anticipate how changes in a sovereigns ESG risk profile can impact debt pricing, says James Lockhart Smith, Head of Markets at Verisk Maplecroft.Users can track how a countrys sustainability performance is evolving and watch for approaching ESG tipping points to help minimise downside risks and identify emerging investment opportunities.
  • For more information on Verisk Maplecrofts Sovereign ESG Ratings, download the whitepaper .

Humanigen Aligns with FDA on Potential Registration Phase 3 Study for Lenzilumab with CAR-T

Retrieved on: 
Monday, January 10, 2022
Biotechnology, FDA, Health, Pharmaceutical, Clinical Trials, SHIELD, Knowledge, GM, Degenerative disease, Rating, LinkedIn, Risk, Security (finance), Goal, Patient, Physician, Chemokine, Asthma, Mayo Clinic, GM-CSF, U.S. Securities and Exchange Commission, Chronic myelomonocytic leukemia, NIH, Toxicity, Forward-looking statement, Neurotoxicity, DLBCL, CRS, COVID, Rheumatoid arthritis, CEO, NHL, Company, Nasdaq, Judgement, FDA, COVID-19, Disease, Twitter, Granulocyte-macrophage colony-stimulating factor, Inflammation, Society, Cytokine release syndrome, Toxic shock syndrome, Adoption, Vaccine, Pharmaceutical industry, Risk management, Hematology, Facebook

In agreement with FDA, we will also seek to demonstrate the beneficial impact that lenzilumab may have on healthcare resource utilization.

Key Points: 
  • In agreement with FDA, we will also seek to demonstrate the beneficial impact that lenzilumab may have on healthcare resource utilization.
  • We are very encouraged with the outcome of our meeting with FDA, said Dr. Cameron Durrant, Chairman and CEO of Humanigen.
  • Defining a potential registration pathway across multiple indications is an important next step in our development of lenzilumab.
  • Humanigens Phase 3 LIVE-AIR study suggests early intervention with lenzilumab may prevent consequences of a full-blown cytokine storm in hospitalized patients with COVID-19.

Credit Conditions To Remain Steady But Inflation And Omicron Pose Threats, Report Says

Retrieved on: 
Tuesday, December 7, 2021
Income, Risk, Awareness, COP26, Carbon, Climate change, EM, EBITDA, Growth, Coal, Rating, S&P Global Ratings, Credit, Food, Vaccine, Weather, Steel, Corporation, GDP, Vaccination, S, EMS, Foundation, S&P Global, Policy, Fossil fuel, COVID-19, Adoption, NEW, Global Research, Shock, Omicron, Renewable energy, Cryptocurrency, Bank

Surging global demand, extraordinarily benign financing conditions, supply chain strains, soaring energy prices, and higher global leverage have all been triggered by the shock of COVID-19. Although credit momentum remains positive--with financing conditions supported by fiscal and monetary policy and solid economic growth--the recovery's foundations are vulnerable to setbacks in light of the new omicron variant, uneven vaccination rates globally, and high inflation.

Key Points: 
  • However, factors including high cost inflation and the new COVID-19 omicron variant could pose a significant risk to that stability.
  • If financing conditions were to tighten sharply, those at the bottom end of the credit scale would endure it first.
  • However, interplaying factors, such as policy shifts or inflation, could lead to a sudden tightening of financing conditions or markets.
  • Climate risk: As global temperatures rise and erratic weather patterns continue to emerge, credit conditions and real assets--in particular infrastructure--will be affected.

Verity Offers Investors Access to Sustainalytics’ ESG Risk Ratings and Controversies Research

Retrieved on: 
Thursday, December 2, 2021
Research, Jerome P. Keuper, CEO, Industry, ESG, Workflow, Platform, Rating, Risk, GLOBE, Verity, Lithium

Sustainalytics is a Morningstar Company and a leading global provider of ESG research, ratings and data.

Key Points: 
  • Sustainalytics is a Morningstar Company and a leading global provider of ESG research, ratings and data.
  • Further enhancing the Verity Platforms robust ESG capabilities, the addition of Sustainalytics ESG Risk Ratings and Controversies Research reports empowers Verity users with a wide range of ESG information including ESG ratings, trends, actionable controversies, analytics, and more.
  • As the demand for timely and reliable ESG data continues to rise, we are proud to provide our customers with Sustainalytics industry-leading ESG research, ratings and data, said Andrew Robson, CEO at Verity.
  • Sustainalytics ESG Risk Ratings help investors to identify and understand financially material ESG risks in their portfolio companies and how that risk might affect performance.

Healthcare Staffing Platform Fusion Marketplace Helps with Nationwide Shortages

Retrieved on: 
Thursday, November 18, 2021
Fusion, Review, Workforce, Rating, Customer success, Industry, Health care, Medicine, Tutoring

Fusion Marketplace is working to solve this problem by giving more power to healthcare professionals and connecting more medical staffing agencies with facilities who are desperately needing help in their communities.

Key Points: 
  • Fusion Marketplace is working to solve this problem by giving more power to healthcare professionals and connecting more medical staffing agencies with facilities who are desperately needing help in their communities.
  • "The team at Fusion Marketplace knows there is a huge demand for good talent, so we are devoting a lot of our resources to bring attention to the industry to attract more people to the healthcare workforce," said Carrie Polak, Fusion Marketplace Manager of Customer Success.
  • Fusion Marketplace is a platform where healthcare professionals can see career opportunities in all 50 states and filter out what their priorities are, seeing only jobs that match their lifestyle.
  • Fusion Marketplace is a staffing recruitment platform where healthcare travelers are in control.

Pennsylvania's Flood Insurance Marketplace Expands with Wright's Launch of Exclusive, Admitted Product

Retrieved on: 
Tuesday, November 16, 2021
AM Best, Lloyd, Industry, Incline, CEO, Technology, Pennsylvania Department of Aging, Insurance, Investment, Wright, Multimedia, Fair Credit Reporting Act, Program, Rating, LLC, Partnership, Risk management, Risk, House, Reinsurance

ST. PETERSBURG, Fla., Nov. 16, 2021 /PRNewswire/ -- Wright National Flood Insurance Services has announced its expansion into Pennsylvania with the introduction of an exclusive, admitted, stand-alone flood product: Wright Residential Private Flood Insurance.

Key Points: 
  • ST. PETERSBURG, Fla., Nov. 16, 2021 /PRNewswire/ --Wright National Flood Insurance Services has announced its expansion into Pennsylvania with the introduction of an exclusive, admitted, stand-alone flood product: Wright Residential Private Flood Insurance.
  • Wright Flood and Incline P&C also have a private flood insurance partnership in Texas, with anticipated plans to expand to additional states in 2022.
  • Wright Residential Private Flood Insurance can be purchased to protect homes against the risk of Pennsylvania flooding since most property policies do not cover the peril of flood.
  • Wright National Flood Insurance Services LLC (WNFIS) offers primary and excess flood products in numerous markets across the United States and are building out our growing Flood Insurance Marketplace.